Elastin-Targeted Pentagalloyl Glucose Nanotherapy Reverses Thoracic and Abdominal Aortic Aneurysms in AngII-BAPN Mice
Annals of Vascular Medicine and Research · 2026
DOI: 10.47739/vascularmedicine.1199 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Vascular Medicine and Research, 2026. Verfasst von David Madukwe und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Elastin degradation is a defining feature of thoracic aortic aneurysm (TAA) and abdominal aortic aneurysm (AAA) progression. Previous work demonstrated that elastin-targeted pentagalloyl glucose nanoparticles (PGG-NPs) reverse established elastase-induced and AngII-induced AAA by reducing inflammation while preserving the extracellular matrix. Whether PGG-NPs is effective in rupture prone AngII-BAPN model characterized by TAA and AAA formation, spontaneous aortic rupture and increased mortality has not been determined.
Methods
ApoE−/− mice received continuous angiotensin II (AngII) infusion (1,500 ng kg-¹ min-¹) and 0.2% β-aminopropionitrile (BAPN) in drinking water to induce TAA or AAA. PGG-NPs (10 mg kg-¹) or Blank-NPs were administered intravenously twice weekly. Gross morphology, Kaplan–Meier survival, aneurysm incidence, histology and α-smooth muscle actin (αSMA) expressions were evaluated after 28 days.
Results
AngII-BAPN induced aneurysm formation in both thoracic and abdominal aortic segments with increased mortality. PGG-NPs treatment significantly improved survival compared with Blank-NP-treated mice (log-rank, P = 0.0132). Gross and histological analyses demonstrated reduced aneurysmal remodeling, decreased pathological medial thickening and enhanced αSMA expression following PGG treatment. AAA incidence was significantly reduced from 75.0% in Blank-NP-treated mice to 23.1% in PGG-treated mice (Fisher’s exact test, P = 0.0092). TAA incidence also decreased from 25.0% to 15.4%, although this difference was not statistically significant (P = 0.663).
Conclusions
PGG-NPs reduce aneurysm burden and improve survival in the AngII-BAPN model while maintaining elastic fiber architecture and vascular smooth muscle integrity. Extension of therapeutic efficacy in ANGII-BAPN model involving both TAA and AAA further supports PGG stabilization of degraded elastin as a promising therapeutic target for aortic aneurysm disease.
Zitieren
APA
Madukwe, D., Nazar, V., Zimmerman, H., Arora, S., & Vyavahare, N. (2026). Elastin-Targeted Pentagalloyl Glucose Nanotherapy Reverses Thoracic and Abdominal Aortic Aneurysms in AngII-BAPN Mice. Annals of Vascular Medicine and Research. https://doi.org/10.47739/vascularmedicine.1199
Vancouver
Madukwe D, Nazar V, Zimmerman H, Arora S, Vyavahare N. Elastin-Targeted Pentagalloyl Glucose Nanotherapy Reverses Thoracic and Abdominal Aortic Aneurysms in AngII-BAPN Mice. Annals of Vascular Medicine and Research. 2026. doi:10.47739/vascularmedicine.1199
BibTeX
@article{Madukwe2026,
author = {Madukwe, David and Nazar, Vida and Zimmerman, Holly and Arora, Shivani and Vyavahare, Narendra},
title = {Elastin-Targeted Pentagalloyl Glucose Nanotherapy Reverses Thoracic and Abdominal Aortic Aneurysms in AngII-BAPN Mice},
journal = {Annals of Vascular Medicine and Research},
year = {2026},
doi = {10.47739/vascularmedicine.1199}
}
EUVIMED